Health Scope

Published by: Kowsar

Effects of a Traditional Iranian Remedy on Cutaneous Leishmaniasis

Masoud Maleki 1 , Mahdi Yousefi 2 , Sayyed Abolghassem Sajadi Tabassi 3 , Hassan Rakhshandeh 3 , Sayyed Mojtaba Mousavi Bazzaz 4 , Gholamreza Haghighi 5 , 6 , * , Shokouh Sadat Hamedi 7 , Sayyed Abdolrahim Rezaee 8 and Fatemeh Haghighi 9
Authors Information
1 Cutaneous Leishmaniasis Research Center, Department of Dermatology, Mashhad University of Medical Sciences, Mashhad, Iran
2 Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3 Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran
4 Department of Social Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
5 School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
6 Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol, Iran
7 Department of Persian Pharmacy, School of Persian and Complementary Medicine, Mashhad, Iran
8 Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
9 Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Article information
  • Health Scope: August 2018, 7 (3); e61206
  • Published Online: August 19, 2018
  • Article Type: Research Article
  • Received: September 2, 2017
  • Accepted: October 9, 2017
  • DOI: 10.5812/jhealthscope.61206

To Cite: Maleki M, Yousefi M, Sajadi Tabassi S A, Rakhshandeh H, Mousavi Bazzaz S M, et al. Effects of a Traditional Iranian Remedy on Cutaneous Leishmaniasis, Health Scope. 2018 ; 7(3):e61206. doi: 10.5812/jhealthscope.61206.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Paniker CKJ, Ghosh S. Paniker's Textbook of medical parasitology. 7th ed. Jaypee Brothers Pvt. Limited; 2013.
  • 2. Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology. 3rd ed. Elsevier Saunders; 2012.
  • 3. Word Health Organization. Leishmaniasis: Fact Sheet N 375. Geneva; 2015. Available from:
  • 4. Asilian A, Jalayer T, Whitworth JA, Ghasemi RL, Nilforooshzadeh M, Olliaro P. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg. 1995;53(6):648-51. [PubMed: 8561269].
  • 5. Reithinger R, Mohsen M, Aadil K, Sidiqi M, Erasmus P, Coleman PG. Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerg Infect Dis. 2003;9(6):727-9. doi: 10.3201/eid0906.030026. [PubMed: 12781016]. [PubMed Central: PMC3000158].
  • 6. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305-18. doi: 10.1016/j.cimid.2004.03.004. [PubMed: 15225981].
  • 7. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997;24(4):684-703. [PubMed: 9145744].
  • 8. Pourmohammadi B, Motazedian MH, Handjani F, Hatam GH, Habibi S, Sarkari B. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis. Southeast Asian J Trop Med Public Health. 2011;42(3):502-8. [PubMed: 21706927].
  • 9. Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol. 2007;25(2):203-11. doi: 10.1016/j.clindermatol.2006.05.008. [PubMed: 17350500].
  • 10. Sharquie KE, Najim RA, Farjou IB. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol. 1997;22(4):169-73. [PubMed: 9499605].
  • 11. Maleki M, Karimi G, Tafaghodi M, Raftari S, Nahidi Y. Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis. Indian J Dermatol. 2012;57(2):118-22. doi: 10.4103/0019-5154.94279. [PubMed: 22615508]. [PubMed Central: PMC3352633].
  • 12. Haghighi G, Maleki M, Rakhshandeh H, Yusofi M. Treatment of cutaneous leishmaniasis using berberis vulgaris: a case report. Avicenna J Phytomedicine. 2015;5.
  • 13. Bayan L, Koulivand PH, Gorji A. Garlic: a review of potential therapeutic effects. Avicenna J Phytomed. 2014;4(1):1-14. [PubMed: 25050296]. [PubMed Central: PMC4103721].
  • 14. Mukherjee PK, Nema NK, Bhadra S, Mukherjee D, Braga FC, Matsabisa MG. Immunomodulatory leads from medicinal plants. Indian J Tradition Knowl. 2014;13(2):235-56.
  • 15. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect. 1999;1(2):125-9. [PubMed: 10594976].
  • 16. Gaafar MR. Efficacy of Allium sativum (garlic) against experimental cryptosporidiosis. Alexandria J Med. 2012;48(1):59-66. doi: 10.1016/j.ajme.2011.12.003.
  • 17. Lun ZR, Burri C, Menzinger M, Kaminsky R. Antiparasitic activity of diallyl trisulfide (dasuansu) ou human and animal pathogenic protozoa (trypanosoma sp., entamoeba histolytica and giardia lamblia) in vitro. Annales-Societe Belge De Medecine Tropicale. Institute of Tropical Medicine; 1994. 51 p.
  • 18. Fliermans CB. Inhibition of Histoplasma capsulatum by garlic. Mycopathol Mycol Appl. 1973;50(3):227-31. [PubMed: 4729537].
  • 19. Zargari A. Medicinal Herbs Book. Tehran: Tehran University Publications; 2011.
  • 20. Arreola R, Quintero-Fabian S, Lopez-Roa RI, Flores-Gutierrez EO, Reyes-Grajeda JP, Carrera-Quintanar L, et al. Immunomodulation and anti-inflammatory effects of garlic compounds. J Immunol Res. 2015;2015:401630. doi: 10.1155/2015/401630. [PubMed: 25961060]. [PubMed Central: PMC4417560].
  • 21. Shirazi MHAAK. Makhzan ol-Advieh. Tehran: Publications and Training of Islamic Revolution; 1992. 1032 p.
  • 22. Avicenna . al-Qanun fi Tibb. Beirut: Dar ol maktabat ol helal; 2009.
  • 23. Nafis E. Al-Shamel fi Al-senaat e Tebiie. Tehran: Iran University Of Medical Science; 2008.
  • 24. Hajjaran H, Mohebali M, Razavi MR, Rezaei S, Kazemi B, Edrissian GH, et al. Identification of leishmania species isolated from human cutaneous leishmaniasis, using random amplified polymorphic DNA (RAPD-PCR). Iran J Public Health. 2004;33(4):8-15.
  • 25. Tuon FF, Amato VS, Graf ME, Siqueira AM, Nicodemo AC, Amato Neto V. Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis. Int J Dermatol. 2008;47(2):109-24. doi: 10.1111/j.1365-4632.2008.03417.x. [PubMed: 18211479].
  • 26. Fatima F, Khalid A, Nazar N, Abdalla M, Mohomed H, Toum AM, et al. In vitro assessment of anti - cutaneous leishmaniasis activity of some Sudanese plants. Turkiye Parazitol Derg. 2005;29(1):3-6. [PubMed: 17167733].
  • 27. Ghazanfari T, Hassan ZM, Khamesipour A. Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium sativum) treatment. J Ethnopharmacol. 2006;103(3):333-7. doi: 10.1016/j.jep.2005.08.026. [PubMed: 16213117].
  • 28. Ghazanfari T, Hassan ZM, Ebtekar M, Ahmadiani A, Naderi G, Azar A. Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice. Scand J Immunol. 2000;52(5):491-5. [PubMed: 11119248].
  • 29. Khoshzaban F, Ghaffarifar F, Mahmmoudzadeh Poornaki A, Ghazanfari T, Naseri M, Khmesipoor A, et al. [Evaluation treatment of cutaneous Leishmaniasis with Garlic extract and R10 fraction in BALB/c, C57BL/6 and outbred SW mice]. Modarres J Med Sci Biologic Pathol. 2011;14(3):25-34. Persian.
  • 30. Samdani A, Samreen J, Iqbal Choudhary M, Atta R. Laboratory studies and clinical trials on new formulations from garlic extract against cutaneous leishmaniasis. Anti-Infective Agents. 2012;10(2):111-6. doi: 10.2174/2211362611208020111.
  • 31. Khalid NM, Mohomed HE, Toum AM, Mubark MA, Magzoub MA. Treatment of cutaneous leishmaniasis with some local sudanese plants (Neem, Garad and Garlic). Türkiye Parazitoloji Dergisi. 2004;28(3):129-32.
  • 32. Gholami AR, Khamesipour A, Momeni A, Ghazanfari T, Nilforoushzadeh MA, Darajeh Z, et al. Treatment of cutaneous leishmaniasis with 5% garlic cream: A randomized, double-blind study. Iran J Dermatology. 2000;3(11):2-6.
  • 33. Babaee Khou L, Mohebali M, Lahiji N, Mehrabi Tavana A. [The therapeutic effects of Eucalyptus, Myrtus, Ferula, Aretmisia, Allium and Urtica extracts against cutaneous leishmaniasis caused by Leishmanaia major in small white mice (out-bred)]. Hakim Res J. 2007;10(2):21-7. Persian.
  • 34. Soto J, Rojas E, Guzman M, Verduguez A, Nena W, Maldonado M, et al. Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis. Clin Infect Dis. 2013;56(9):1255-60. doi: 10.1093/cid/cit049. [PubMed: 23390069].
  • 35. Monge-Maillo B, Lopez-Velez R. Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis. Drugs. 2013;73(17):1889-920. doi: 10.1007/s40265-013-0132-1. [PubMed: 24170665].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments